LGD-4033

Other names: VK5211, anabolicum, LGD4033, VK-5211, 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile, 4-[(2R)-w-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile, Ligandrol

Classifications: 6000

Reasons for prohibition: - WADA S1: Anabolic Agents (source) - Unapproved Drug - FDA Statement

References: - {'title': 'NIH NCATS Inxight Drugs entry: VK-5211', 'url': 'https://drugs.ncats.io/drug/1EJT54415A'} - {'title': 'FDA warns against using SARMs in body-building products', 'url': 'https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products'}

Reason: WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs

Searchable name: lgd-4033

GUID: 16ca3215-e10f-4609-bf56-f5ea39a0383a

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1720807170, "_nanoseconds": 141000000}